T655-0332 Screening compound: 2-(propane-1-sulfonyl)-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

T655-0332 Screening compound: 2-(propane-1-sulfonyl)-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane
T655-0332 Screening compound: 2-(propane-1-sulfonyl)-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound T655-0332
2-(propane-1-sulfonyl)-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T655-0332

Molecular Formula

C18H24N4O4S (C18 H24 N4 O4 S)

Compound Name

2-(propane-1-sulfonyl)-4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

IUPAC name

2-(propane-1-sulfonyl)-4-[5-(pyridin-4-yl)-134-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decane

SMILES

CCCS(N(C1)CC2(CCOCC2)C1c1nnc(-c2ccncc2)o1)(=O)=O

InChI

InChI=1S/C18H24N4O4S/c1-2-11-27(23,24)22-12-15(18(13-22)5-9-25-10-6-18)17-21-20-16(26-17)14-3-7-19-8-4-14/h3-4,7-8,15H,2,5-6,9-13H2,1H3/t15-/m0/s1

InChI Key

QUGYPWCYSNNFCB-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD29002510

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

392.48

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.038

Distribution Coefficient, logD

1.037

Water Solubility, LogSw

-1.87

Polar Surface Area

79.850

Acid Dissociation Constant (pKa)

22.48

Base Dissociation Constant (pKb)

4.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.10

T655-0332 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with T655-0332 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T655-0332?
Check Price and Availability of T655-0332, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T655-0332 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T655-0332
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T655-0332
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T655-0332 available by request